AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression
Clinical trial NCT03078322 · COMPLETED
Trial details
- NCT number
- NCT03078322
- Sponsor
- VistaGen Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2019-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.